BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2801828
Number of visits today
1307
Number of downloads
2055768
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Shih CA, Chen WC. Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy. World J Clin Cases 2021; 9(21): 5769-5781 [PMID: 34368296 DOI: 10.12998/wjcc.v9.i21.5769] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zheng J, Wang Z, Feng B. Hepatitis B functional cure and immune response. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1075916] [Reference Citation Analysis]
2 Sagnelli C, Sica A, Creta M, Borsetti A, Ciccozzi M, Sagnelli E. Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19. Pathogens 2022;11:567. [DOI: 10.3390/pathogens11050567] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Yuan C, Peng J, Xia R, He J, Qiu T, Yao Y. Reactivation of Occult Hepatitis B Virus Infection During Long-Term Entecavir Antiviral Therapy. Front Microbiol 2022;13:865124. [DOI: 10.3389/fmicb.2022.865124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pereira SL, Duro R, Sarmento A. Late Hepatitis B reactivation after treatment with rituximab. IDCases 2022;27:e01393. [DOI: 10.1016/j.idcr.2022.e01393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345